5:46 PM
Apr 02, 2014
 |  BC Extra  |  Financial News

Oncodesign, Genomic Vision price French IPOs

Oncodesign S.A. (Euronext:ALONC) and Genomic Vision S.A. (Euronext:GV) both raised money in IPOs on Euronext Paris. Oncodesign raised EUR 12.2 million ($16.8 million) through the sale of 1.7 million new shares at EUR 7.34, which values...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >